Schlick, K.; Magnes, T.; Huemer, F.; Ratzinger, L.; Weiss, L.; Pichler, M.; Melchardt, T.; Greil, R.; Egle, A.
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients. J. Clin. Med. 2019, 8, 1791.
https://doi.org/10.3390/jcm8111791
AMA Style
Schlick K, Magnes T, Huemer F, Ratzinger L, Weiss L, Pichler M, Melchardt T, Greil R, Egle A.
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients. Journal of Clinical Medicine. 2019; 8(11):1791.
https://doi.org/10.3390/jcm8111791
Chicago/Turabian Style
Schlick, Konstantin, Teresa Magnes, Florian Huemer, Lukas Ratzinger, Lukas Weiss, Martin Pichler, Thomas Melchardt, Richard Greil, and Alexander Egle.
2019. "C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients" Journal of Clinical Medicine 8, no. 11: 1791.
https://doi.org/10.3390/jcm8111791
APA Style
Schlick, K., Magnes, T., Huemer, F., Ratzinger, L., Weiss, L., Pichler, M., Melchardt, T., Greil, R., & Egle, A.
(2019). C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling Overall Survival Prediction in Pancreatic Cancer Patients. Journal of Clinical Medicine, 8(11), 1791.
https://doi.org/10.3390/jcm8111791